press-release
We are thrilled to announce that ArtiQ has been acquired by Clario, a leading healthcare research and technology company renowned for its groundbreaking contributions to clinical evidence generation.
Clario integrates AI into clinical trial data collection for spirometry with new partnership with ArtiQ
Artificiële Intelligentie helpt huisartsen longziekten opsporen
ArtiQ ranked in the CB Insights’ 2022 ‘Digital Health 150’ List
NuvoAir Partners with ArtiQ to Provide AI-Based Over-Reading of Spirometry to Improve Efficiency of Clinical Trials
ArtiQ and patientMpower join forces to provide the best quality home spirometry to patients and healthcare professionals
Boehringer Ingelheim and ArtiQ join forces to help bring specialist-level expertise to all levels of care.
ArtiQ presented at the International Respiratory Summit at the EXPO 2020.
ArtiQ Wins UK Government Funding for its AI Algorithms to Support Timely Diagnosis of Lung Diseases
ArtiQ announces a partnership with Vyaire Medical to bring its ArtiQ.PFT software to hospitals across Europe.
ArtiQ obtains ISO 13485 and CE marking (MDR) certification.
ArtiQ awarded a € 450 000 grant from VLAIO
Diagnosis of Interstitial Lung Disease (ILD) - Interview with professor Wim Wuyts
Watch the presentation below to get an overview of the latest applications of AI in respiratory medicine and to learn how doctors and AI can work together as a complimentary team.
Standardization of ATS/ERS quality criteria or spirometry - interview wit Nilakash Das.
ArtiQ in Artsenkrant.
ArtiQ, a KU Leuven spin-off company which helps doctors diagnose, treat and monitor respiratory problems, announces that it has successfully concluded its seed financing round, raising € 1 million euro. The financing will be used to launch ArtiQ|PFT, a decision support tool that offers pulmonologists a fast, reliable and standardized evaluation of a patient’s lung function.